NCT07128654View on ClinicalTrials.gov

A Bioequivalence Study of CT-L02 Compared to Co-administration (CTL0201 and CTL0202) in Healthy Volunteers

PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Healthy
Interventions
DRUG

CTL02

FDC tablet, single dose, oral administration

DRUG

CTL0201

Nesina, tablet, single dose, oral administration

DRUG

CTL0202

Jardiance, tablet, single dose, oral administration

Trial Locations (1)

Unknown

RECRUITING

H+ Yangji Hospital, Seoul

Sponsors

Lead Sponsor

Celltrion
All Listed Sponsors
lead

Celltrion

INDUSTRY

NCT07128654 - A Bioequivalence Study of CT-L02 Compared to Co-administration (CTL0201 and CTL0202) in Healthy Volunteers | Biotech Hunter | Biotech Hunter